Thus, in NSCLC, tumour growth was associated with a decrease of circulating antitumor Th1 responses, but an accumulation of exhausted PD-1+/TIM-3+ CD4+ T cells. This evidence concerns the gene HAVCR2 and non-small cell lung carcinoma.